Presentation

Each tablet contains Mebhydrolin Napadisylate INN 76 mg equivalent to Mebhydrolin 50 mg.

Description

Mebhydrolin diminishes or abolishes the main actions of histamine in the body by blocking of histamine receptors.

Indications

Allergic disease or symptoms such as urticaria, pruritus of various origin, eczema, itching, drug rash, insect bites, allergic conjunctivitis, dermatitis of nutritional origin, hay fever, vasomotor rhinitis, allergic asthma.

Dosage & Administration

Adults and children over 10 years: 2-6 tablets daily

Children 5-10 years: 2-4 tablets daily

Children 2-5 years: 1-3 tablets daily

Children upto 2 years: 1-2 tablets daily

Treatment should be given in several single doses daily. Mebhydrolin may be swallowed during or shortly after meals. For children, the tablet may be crushed and mixed with food.

Side Effects

Lassitude, dizziness, hypotension, muscular weakness, nausea, vomiting, diarrhoea or constipation, epigastric pain, headache, blurred vision, tinnitus, depression, nightmares, anorexia, dryness of the mouth, tightness of the chest, tingling, sedation, drowsiness etc. may occur.

Precautions

The substance may cause drowsiness, if affected, driving or operating machinery & alcoholic drinks should be avoided.

Use in Pregnancy & Lactation

Safety in pregnancy and lactation has not been established.

Commercial Pack

Each box contains 10 blister strips of 10 tablets.